[1]
B. Kazeminezhad, S. A. Mirafsharieh, K. Dinyari, D. Azizi, and A. Ebrahimi, “Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases”, Turkish Journal of Gastroenterology, vol. 25, no. 3, pp. 253–256, Jan. 2014.